These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2588708)

  • 1. [Inhalation of carbon disulfide--studies of carbon disulfide uptake in dynamic dose administration lasting 4 hours].
    Herrmann G; Leuschke W; Viehrig J
    Z Gesamte Hyg; 1989 Sep; 35(9):537-41. PubMed ID: 2588708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbon disulfide neurotoxicity in rats: II. Toxicokinetics.
    Moorman MP; Sills RC; Collins BJ; Morgan DL
    Neurotoxicology; 1998 Feb; 19(1):89-97. PubMed ID: 9498225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reduction of health risk factors in workers exposed to carbon disulfide].
    Głuszcz M; Sułkowski W; Rogaczewska T; Wrońska-Nofer T; Sińczuk-Walczak H; Leśnik H; Poborc-Godlewska J
    Med Pr; 1984; 35(3):217-21. PubMed ID: 6503689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of the exposure test and the gas concentration measurements in the breathing zones for the evaluation of the workers' exposure to carbon disulfide].
    Pankiewicz K; Krajewski J
    Med Pr; 1982; 33(5-6):289-93. PubMed ID: 7182710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the biological exposure test "CS2 in urine"].
    Herrmann G; Leuschke W; Viehrig J
    Z Gesamte Hyg; 1990 Nov; 36(11):596-9. PubMed ID: 2085038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbon disulfide neurotoxicity in rats: VII. Behavioral evaluations using a functional observational battery.
    Moser VC; Phillips PM; Morgan DL; Sills RC
    Neurotoxicology; 1998 Feb; 19(1):147-57. PubMed ID: 9498230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhalation uptake of carbon disulfide].
    Herrmann G; Leuschke W; Viehrig J
    Z Gesamte Hyg; 1982 May; 28(5):305-10. PubMed ID: 7113303
    [No Abstract]   [Full Text] [Related]  

  • 8. CS2-mediated cross-linking of erythrocyte spectrin and neurofilament protein: dose response and temporal relationship to the formation of axonal swellings.
    Valentine WM; Amarnath V; Graham DG; Morgan DL; Sills RC
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):95-105. PubMed ID: 9007038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of carbon disulfide exposure data and the association between carbon disulfide exposure and ischemic heart disease mortality.
    Price B; Bergman TS; Rodríguez M; Henrich RT; Moran EJ
    Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):119-28. PubMed ID: 9339488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updating of hygiene standards for carbon disulfide based on health risk assessment.
    Stetkiewicz J; Wrońska-Nofer T
    Int J Occup Med Environ Health; 1998; 11(2):129-43. PubMed ID: 9753892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Carbon disulfide excretion in urine--a biological exposure test for the workplace and environmental concentration ranges].
    Winkelmann H; Prösch J; Engewald W; Horn K
    Z Gesamte Hyg; 1991 Mar; 37(3):102-4. PubMed ID: 2038856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbon disulfide. I. The metabolism of inhaled carbon disulfide in the rat.
    McKenna MJ; DiStefano V
    J Pharmacol Exp Ther; 1977 Aug; 202(2):245-52. PubMed ID: 886464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbon disulfide neurotoxicity in rats: VI. Electrophysiological examination of caudal tail nerve compound action potentials and nerve conduction velocity.
    Herr DW; Vo KT; Morgan DL; Sills RC
    Neurotoxicology; 1998 Feb; 19(1):129-46. PubMed ID: 9498229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covalent modification of hemoglobin by carbon disulfide: III. A potential biomarker of effect.
    Valentine WM; Amarnath V; Amarnath K; Erve JC; Graham DG; Morgan DL; Sills RC
    Neurotoxicology; 1998 Feb; 19(1):99-107. PubMed ID: 9498226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The influence of chronic exposure to carbon disulfide on metabolism of catecholamines and serotonin in women].
    Kuligowski D
    Ann Acad Med Stetin; 1996; 42():139-56. PubMed ID: 9199118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Health conditions of workers exposed to CS-2 in xanthate plants].
    Bielecka W; Liniewiecki T; Kucharska E; Buchwald Z; Kucharski R
    Med Pr; 1977; 28(6):525-30. PubMed ID: 609330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhaled uptake of carbon disulfide - studies of CS2-uptake under dosed dynamic load].
    Herrmann G; Leuschke W; Viehrig J
    Z Gesamte Hyg; 1983 Aug; 29(8):444-8. PubMed ID: 6636890
    [No Abstract]   [Full Text] [Related]  

  • 18. [Inhalation of carbon disulfide--studies of carbon disulfide intake under dynamic doses].
    Herrmann G; Leuschke W; Viehrig J
    Z Gesamte Hyg; 1985 Jun; 31(6):369-72. PubMed ID: 4036202
    [No Abstract]   [Full Text] [Related]  

  • 19. A benchmark concentration for carbon disulfide: analysis of the NIOSH carbon disulfide exposure database.
    Price B; Berner T; Henrich RT; Stewart JM; Moran EJ
    Regul Toxicol Pharmacol; 1996 Oct; 24(2 Pt 1):171-6. PubMed ID: 8933630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental and biological monitoring in carbon disulfide exposure assessment.
    Krstev S; Perunicić B; Farkić B; Varagić M
    Med Lav; 1993; 84(6):473-81. PubMed ID: 8177132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.